Technical Analyst, Rajat K Bose is of the view that one should exit Ranbaxy Laboratories.
Bose told CNBC-TV18, "If one get an opportunity to gets out of Ranbaxy better get out. I for one would not be buying into a stock, which looks like an Enron on the charts."
Source: MoneyControl
DISCLAIMER: The author is not a registered stockbroker nor a registered advisor and does not give investment advice. His comments are an expression of opinion only and should not be construed in any manner whatsoever as recommendations to buy or sell a stock, option, future, bond, commodity, index or any other financial instrument at any time. While he believes his statements to be true, they always depend on the reliability of his own credible sources. The author recommends that you consult with a qualified investment advisor, one licensed by appropriate regulatory agencies in your legal jurisdiction, before making any investment decisions, and that you confirm the facts on your own before making important investment commitments.
No comments:
Post a Comment